Lipopolysaccharide Primes Human Macrophages for Noncanonical Inflammasome-Induced Extracellular Vesicle Secretion

Wojciech Cypryk,Liliana Czernek,Katarzyna Horodecka,Jędrzej Chrzanowski,Marcin Stańczak,Katariina Nurmi,Marcelina Bilicka,Mariusz Gadzinowski,Aurelia Walczak-Drzewiecka,Maria Stensland,Kari Eklund,Wojciech Fendler,Sampsa Matikainen,Tuula A. Nyman
DOI: https://doi.org/10.4049/jimmunol.2200444
2023-02-01
The Journal of Immunology
Abstract:Abstract Human macrophages secrete extracellular vesicles (EVs) loaded with numerous immunoregulatory proteins. Vesicle-mediated protein secretion in macrophages is regulated by poorly characterized mechanisms; however, it is now known that inflammatory conditions significantly alter both the quantities and protein composition of secreted vesicles. In this study, we employed high-throughput quantitative proteomics to characterize the modulation of EV-mediated protein secretion during noncanonical caspase-4/5 inflammasome activation via LPS transfection. We show that human macrophages activate robust caspase-4–dependent EV secretion upon transfection of LPS, and this process is also partially dependent on NLRP3 and caspase-5. A similar effect occurs with delivery of the LPS with Escherichia coli–derived outer membrane vesicles. Moreover, sensitization of the macrophages through TLR4 by LPS priming prior to LPS transfection dramatically augments the EV-mediated protein secretion. Our data demonstrate that this process differs significantly from canonical inflammasome activator ATP-induced vesiculation, and it is dependent on the autocrine IFN signal associated with TLR4 activation. LPS priming preceding the noncanonical inflammasome activation significantly enhances vesicle-mediated secretion of inflammasome components caspase-1, ASC, and lytic cell death effectors GSDMD, MLKL, and NINJ1, suggesting that inflammatory EV transfer may exert paracrine effects in recipient cells. Moreover, using bioinformatics methods, we identify 15-deoxy-Δ12,14-PGJ2 and parthenolide as inhibitors of caspase-4–mediated inflammation and vesicle secretion, indicating new therapeutic potential of these anti-inflammatory drugs.
immunology
What problem does this paper attempt to address?